Copyright: ©Author(s) 2026.
World J Diabetes. May 15, 2026; 17(5): 117635
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.117635
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.117635
Figure 3 Zuo Gui pill cooperates with Fer-1 to reduce symptoms and oxidative stress in type 2 diabetic osteoporosis.
A: Weekly changes in rat blood glucose after type 2 diabetic osteoporosis model construction; B: Weekly changes in rat body weight after type 2 diabetic osteoporosis model construction; C: Serum levels of total cholesterol, triglycerides, and low-density lipoprotein cholesterol; D: Serum International Federation of Clinical Chemistry and Laboratory Medicine-glycated hemoglobin, insulin levels; E: Levels of malondialdehyde, superoxide dismutase, and glutathione/glutathione disulfide in serum. Data were expressed as mean ± SD (n = 3). aP < 0.05,bP < 0.01,cP < 0.001. GSH/GSSH: Glutathione/glutathione disulfide; IFCC-HbA1c: International Federation of Clinical Chemistry and Laboratory Medicine-glycated hemoglobin; LDL-C: Low-density lipoprotein cholesterol; MDA: Malondialdehyde; MET: Metformin; SOD: Superoxide dismutase; TC: Total cholesterol; TG: Triglycerides; ZGP: Zuo Gui pill.
- Citation: Zhao Y, Feng XZ, Cao WQ, Chen YR, Yang Y, Liu JC, Xu A, Ren YL, Wang ZM. Zuo Gui pill alleviates M1 macrophage polarization in type 2 diabetic osteoporosis through the Nrf2/HO-1/XCT/GPX4 pathway. World J Diabetes 2026; 17(5): 117635
- URL: https://www.wjgnet.com/1948-9358/full/v17/i5/117635.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i5.117635